Asthma and COVID-19: a systematic review
Abstract Background Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with other infectious diseases that affect the respiratory tract, asthma has been cited as a potential risk factor for severe COVID-...
Main Authors: | Natália F. Mendes, Carlos P. Jara, Eli Mansour, Eliana P. Araújo, Licio A. Velloso |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-020-00509-y |
Similar Items
-
Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19
by: Larissa C. M. Bueno, et al.
Published: (2022-06-01) -
Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trialResearch in context
by: D. Clark Files, et al.
Published: (2023-04-01) -
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group
by: Clarissa Baldotto, et al.
Published: (2020-06-01) -
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01) -
Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
by: Benjamin P. Geisler, et al.
Published: (2021-05-01)